
Amy E. Juedes
Examiner (ID: 36, Phone: (571)272-4471 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1288 |
| Issued Applications | 445 |
| Pending Applications | 147 |
| Abandoned Applications | 714 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11331889
[patent_doc_number] => 09523126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-20
[patent_title] => 'Compositions and methods for modulating an immune response'
[patent_app_type] => utility
[patent_app_number] => 14/282338
[patent_app_country] => US
[patent_app_date] => 2014-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 19320
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14282338
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/282338 | Compositions and methods for modulating an immune response | May 19, 2014 | Issued |
Array
(
[id] => 10997658
[patent_doc_number] => 20160194605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'DESIGN AND USE OF SPECIFIC REGULATORY T-CELLS TO INDUCE IMMUNE TOLERANCE'
[patent_app_type] => utility
[patent_app_number] => 14/889962
[patent_app_country] => US
[patent_app_date] => 2014-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7454
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14889962
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/889962 | Use of specific regulatory T-cells to induce immune tolerance | May 8, 2014 | Issued |
Array
(
[id] => 10700568
[patent_doc_number] => 20160046715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'T REGULATORY CELLS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/783258
[patent_app_country] => US
[patent_app_date] => 2014-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12946
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783258
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/783258 | T REGULATORY CELLS AND USES THEREOF | May 6, 2014 | Abandoned |
Array
(
[id] => 10926289
[patent_doc_number] => 20140329310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'Activated T Cells'
[patent_app_type] => utility
[patent_app_number] => 14/272404
[patent_app_country] => US
[patent_app_date] => 2014-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 17025
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14272404
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/272404 | Activated T Cells | May 6, 2014 | Abandoned |
Array
(
[id] => 10932166
[patent_doc_number] => 20140335186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCING CD4+ REGULATORY T CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/269042
[patent_app_country] => US
[patent_app_date] => 2014-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22997
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14269042
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/269042 | METHODS AND COMPOSITIONS FOR ENHANCING CD4+ REGULATORY T CELLS | May 1, 2014 | Pending |
Array
(
[id] => 10919195
[patent_doc_number] => 20140322214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'THERAPEUTIC APPLICATIONS OF ACTIVATION OF HUMAN ANTIGEN-PRESENTING CELLS THROUGH DECTIN-1'
[patent_app_type] => utility
[patent_app_number] => 14/264967
[patent_app_country] => US
[patent_app_date] => 2014-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18243
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14264967
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/264967 | THERAPEUTIC APPLICATIONS OF ACTIVATION OF HUMAN ANTIGEN-PRESENTING CELLS THROUGH DECTIN-1 | Apr 28, 2014 | Abandoned |
Array
(
[id] => 10737274
[patent_doc_number] => 20160083424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'COMPOSITIONS AND METHODS FOR TARGETING ANTIGEN-PRESENTING CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/786435
[patent_app_country] => US
[patent_app_date] => 2014-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15760
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786435
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/786435 | COMPOSITIONS AND METHODS FOR TARGETING ANTIGEN-PRESENTING CELLS | Apr 23, 2014 | Abandoned |
Array
(
[id] => 11225359
[patent_doc_number] => 09453074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)'
[patent_app_type] => utility
[patent_app_number] => 14/254206
[patent_app_country] => US
[patent_app_date] => 2014-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 18530
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14254206
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/254206 | Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) | Apr 15, 2014 | Issued |
Array
(
[id] => 10932083
[patent_doc_number] => 20140335104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells'
[patent_app_type] => utility
[patent_app_number] => 14/252535
[patent_app_country] => US
[patent_app_date] => 2014-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 31484
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14252535
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/252535 | Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells | Apr 13, 2014 | Abandoned |
Array
(
[id] => 9888817
[patent_doc_number] => 08975070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-10
[patent_title] => 'Process for producing cytotoxic lymphocyte'
[patent_app_type] => utility
[patent_app_number] => 14/250227
[patent_app_country] => US
[patent_app_date] => 2014-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25665
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14250227
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/250227 | Process for producing cytotoxic lymphocyte | Apr 9, 2014 | Issued |
Array
(
[id] => 10722760
[patent_doc_number] => 20160068908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-10
[patent_title] => 'HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/781359
[patent_app_country] => US
[patent_app_date] => 2014-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11499
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781359
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/781359 | Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cells | Apr 9, 2014 | Issued |
Array
(
[id] => 14697593
[patent_doc_number] => 10376518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Methods for the treatment of autoimmune diseases
[patent_app_type] => utility
[patent_app_number] => 14/780104
[patent_app_country] => US
[patent_app_date] => 2014-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 10
[patent_no_of_words] => 8741
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14780104
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/780104 | Methods for the treatment of autoimmune diseases | Mar 27, 2014 | Issued |
Array
(
[id] => 9771097
[patent_doc_number] => 20140294759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'TARGETING REGULATORY T CELLS WITH HETERODIMERIC PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/217166
[patent_app_country] => US
[patent_app_date] => 2014-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 171
[patent_figures_cnt] => 171
[patent_no_of_words] => 42253
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14217166
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/217166 | Targeting regulatory T cells with heterodimeric proteins | Mar 16, 2014 | Issued |
Array
(
[id] => 10684298
[patent_doc_number] => 20160030443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING REGULATORY T CELL FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 14/775725
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9566
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775725
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/775725 | METHODS AND COMPOSITIONS FOR MODULATING REGULATORY T CELL FUNCTION | Mar 13, 2014 | Abandoned |
Array
(
[id] => 9771172
[patent_doc_number] => 20140294836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'TARGETING REGULATORY T CELLS WITH HETERODIMERIC PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/214475
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 25410
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14214475
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/214475 | Targeting regulatory T cells with heterodimeric proteins | Mar 13, 2014 | Issued |
Array
(
[id] => 9642564
[patent_doc_number] => 20140220675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'PLATFORM OF DENDRITIC CELL (DC)-BASED VACCINATION'
[patent_app_type] => utility
[patent_app_number] => 14/195834
[patent_app_country] => US
[patent_app_date] => 2014-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7153
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14195834
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/195834 | PLATFORM OF DENDRITIC CELL (DC)-BASED VACCINATION | Mar 2, 2014 | Abandoned |
Array
(
[id] => 9670537
[patent_doc_number] => 20140234400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells'
[patent_app_type] => utility
[patent_app_number] => 14/193498
[patent_app_country] => US
[patent_app_date] => 2014-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19393
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14193498
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/193498 | Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells | Feb 27, 2014 | Abandoned |
Array
(
[id] => 9560620
[patent_doc_number] => 20140178334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'Methods and compositions for liquidation of tumors'
[patent_app_type] => utility
[patent_app_number] => 14/193832
[patent_app_country] => US
[patent_app_date] => 2014-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6915
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14193832
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/193832 | Methods and compositions for liquidation of tumors | Feb 27, 2014 | Abandoned |
Array
(
[id] => 14823691
[patent_doc_number] => 10408848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Skin model
[patent_app_type] => utility
[patent_app_number] => 14/770949
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 7076
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770949
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/770949 | Skin model | Feb 26, 2014 | Issued |
Array
(
[id] => 14823691
[patent_doc_number] => 10408848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Skin model
[patent_app_type] => utility
[patent_app_number] => 14/770949
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 7076
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770949
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/770949 | Skin model | Feb 26, 2014 | Issued |